Clinical trial
Immunomonitoring and Multiple Myeloma: Impact of Lenalidomide on Immune Checkpoint
NCT04872023 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunomonitoring and Multiple Myeloma: Impact of Lenalidomide on Immune Checkpoint
- Lead sponsor
- Rennes University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 29, 2021
- Completion date
- January 27, 2023
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.